Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Original |
USD | Fiscal Year Ending | | Latest |
(in millions) | Dec-14 | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | Dec-22 | Dec-23 | | Jun-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 90 | (0) | 74 | 243 | (85) | 176 | 212 | 283 | (226) | 40 | | 117 |
% Growth | NA | -100.1% | -74817.8% | 230.4% | -135.1% | -306.6% | 20.3% | 33.4% | -180.0% | -117.6% | | |
| | | | | | | | | | | | |
Cost of Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Gross Profit | 90 | (0) | 74 | 243 | (85) | 176 | 212 | 283 | (226) | 40 | | 117 |
% Revenue | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | | 100.0% |
| | | | | | | | | | | | |
Research and Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Selling and Marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
General and Admin | (37) | (22) | (28) | (69) | (26) | (31) | (43) | (73) | (16) | (12) | | (12) |
Other Inc / (Exp) | 1 | (1) | 0 | (2) | (2) | (5) | (4) | (9) | 1 | (1) | | (1) |
Total Operating Exp | (36) | (23) | (28) | (71) | (28) | (36) | (47) | (82) | (15) | (13) | | (13) |
| | | | | | | | | | | | |
Operating Income | 53 | (23) | 46 | 172 | (114) | 140 | 165 | 201 | (241) | 27 | | 104 |
% Revenue | 59.5% | 23489.7% | 62.2% | 70.7% | 133.3% | 79.5% | 77.7% | 71.1% | 106.6% | 67.4% | | 88.8% |
| | | | | | | | | | | | |
Interest Expense | (1) | (2) | (3) | (1) | (2) | (3) | (2) | (2) | (12) | (16) | | (11) |
Pre-tax Income | 52 | (25) | 43 | 171 | (116) | 137 | 162 | 199 | (254) | 11 | | 93 |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Net Income to Company | 52 | (25) | 43 | 171 | (116) | 137 | 162 | 199 | (254) | 11 | | 93 |
% Margin | 58.0% | 25197.0% | 58.8% | 70.2% | 136.2% | 77.7% | 76.6% | 70.4% | 112.1% | 28.6% | | 79.3% |
| | | | | | | | | | | | |
Minority Interest in Earnings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Net Income to Stockholders | 52 | (25) | 43 | 171 | (116) | 137 | 162 | 199 | (254) | 11 | | 93 |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | 52 | (25) | 43 | 171 | (116) | 137 | 162 | 199 | (254) | 11 | | 93 |
% Margin | 58.0% | 25197.0% | 58.8% | 70.2% | 136.2% | 77.7% | 76.6% | 70.4% | 112.1% | 28.6% | | 79.3% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | 1.05 | (0.50) | 0.87 | 3.45 | (2.46) | 3.47 | 4.53 | 6.12 | (9.23) | 0.46 | | 4.45 |
Diluted EPS (Continuing Ops) | 1.05 | (0.50) | 0.87 | 3.45 | (2.46) | 3.47 | 4.53 | 6.12 | (9.23) | 0.46 | | 4.45 |
| | | | | | | | | | | | |
WA Basic Shares Out. | 49.44 | 49.52 | 49.52 | 49.50 | 47.19 | 39.47 | 35.90 | 32.50 | 27.50 | 24.88 | | 16.71 |
WA Diluted Shares Out. | 49.44 | 49.52 | 49.52 | 49.50 | 47.19 | 39.47 | 35.90 | 32.50 | 27.50 | 24.88 | | 16.71 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | 52 | (25) | 43 | 171 | (116) | 137 | 162 | 199 | (254) | 11 | | 93 |
Addback: Net Interest Expense | 1 | 2 | 3 | 1 | 2 | 3 | 2 | 2 | 12 | 16 | | 11 |
Addback: Other Non Operating Expenses, Total | (1) | 1 | (1) | 0 | (1) | 0 | 1 | 3 | (3) | (0) | | (0) |
Addback: Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Restructuring Charges | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | 0 | 1 | 1 | 2 | 3 | 4 | 3 | 6 | 2 | 1 | | 2 |
Addback: Gain (Loss) On Sale Of Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Asset Writedown | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Adjusted EBITDA | 53 | (22) | 46 | 174 | (112) | 145 | 169 | 210 | (242) | 28 | | 106 |
% Margin | 58.9% | 22109.3% | 62.1% | 71.7% | 130.8% | 82.2% | 79.5% | 74.2% | 106.9% | 70.6% | | 89.9% |
| | | | | | | | | | | | |
Adjusted EBIT | 53 | (22) | 46 | 174 | (112) | 145 | 169 | 210 | (242) | 28 | | 106 |
% Margin | 58.9% | 22109.3% | 62.1% | 71.7% | 130.8% | 82.2% | 79.5% | 74.2% | 106.9% | 70.6% | | 89.9% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | 52 | (25) | 43 | 171 | (116) | 137 | 162 | 199 | (254) | 11 | | 93 |
Addback: Unusual Items | 0 | 1 | 1 | 2 | 3 | 4 | 3 | 6 | 2 | 1 | | 2 |
Less: Tax Benefit of Unusual Items (26%) | (0) | (0) | (0) | (1) | (1) | (1) | (1) | (2) | (1) | (0) | | (0) |
Adjusted Net Income | 52 | (24) | 44 | 172 | (114) | 140 | 164 | 204 | (252) | 12 | | 94 |
% Margin | 58.0% | 24807.0% | 59.6% | 70.9% | 133.7% | 79.6% | 77.5% | 72.0% | 111.3% | 31.3% | | 80.2% |